Genextra S.p.A. 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Aug 17, 2020
Insider Transaction Report
Form 4
Genextra S.p.A.
10% Owner
Transactions
- Sale
Common stock, par value $0.001 per share
2020-08-14$50.55/sh−54,600$2,760,112→ 5,362,400 total - Sale
Common stock, par value $0.001 per share
2020-08-17$50.15/sh−126,888$6,362,913→ 5,235,512 total - Sale
Common stock, par value $0.001 per share
2020-08-17$46.75/sh−1,235,512$57,760,186→ 4,000,000 total - Sale
Common stock, par value $0.001 per share
2020-08-13$52.60/sh−83,000$4,365,451→ 5,417,000 total
Footnotes (1)
- [F1]Genextra S.p.A. will apply the proceeds from the sales to pay off outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.